Login / Signup

Non-bleeding Adverse Events with the Use of Direct Oral Anticoagulants: A Sequence Symmetry Analysis.

Géric MauraCécile BillionnetJoël CosteAlain WeillAnke NeumannAntoine Pariente
Published in: Drug safety (2018)
Results of this nationwide study suggest that DOACs are associated with rare but severe liver injury and more frequent gastrointestinal disorders. A low risk of kidney injury with DOAC therapy can also not be excluded.
Keyphrases
  • direct oral anticoagulants
  • liver injury
  • drug induced
  • atrial fibrillation
  • venous thromboembolism
  • early onset
  • stem cells
  • mesenchymal stem cells
  • cell therapy
  • smoking cessation
  • data analysis